Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
Front Oncol
; 9: 150, 2019.
Article
in En
| MEDLINE
| ID: mdl-30931258
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Front Oncol
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication:
Suiza